Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine post-exposure prophylaxis for COVID-19 in healthcare workers
jRCTs051200060Completed
- Sponsor
- Osaka Metropolitan University
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Osaka Metropolitan University. Primary endpoint: Serious adverse events during the drug administration period. Started Sep 2020; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCTs051200060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051200060.